Callan Family Office LLC Takes $13.76 Million Position in Merck KGaA $MKGAF

Callan Family Office LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 107,070 shares of the company’s stock, valued at approximately $13,758,000. Callan Family Office LLC owned 0.08% of Merck KGaA as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC purchased a new position in Merck KGaA in the second quarter worth approximately $25,000. Kilter Group LLC acquired a new position in Merck KGaA during the 2nd quarter worth approximately $62,000. Addison Advisors LLC purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $90,000. Hara Capital LLC purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $110,000. Finally, Comprehensive Financial Planning Inc. PA acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at $134,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Price Performance

Merck KGaA stock opened at $163.21 on Friday. The stock has a market cap of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The company has a fifty day simple moving average of $162.62 and a 200-day simple moving average of $148.46. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.